United States Neuromodulation Devices Market Report 2017

December 2017 | 103 pages | ID: UF217E4F153EN
QYResearch

Abstracts

In this report, the United States Neuromodulation Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Neuromodulation Devices in these regions, from 2012 to 2022 (forecast).

United States Neuromodulation Devices market competition by top manufacturers/players, with Neuromodulation Devices sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Medtronic
• Boston Scientific Corporation
• St.Jude Medical
• Synapse Biomedical
• Nevro
• Neurosigma
• Neuropace
• Neuronetics
• Cyberonics
• BioControl Medical

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Deep Brain Stimulation (DBS) Systems
• Spinal Cord Stimulator (SCS) Systems
• Diaphragm Pacing System (DPS)
• Respiratory Electrical Stimulation (RES)
• Vagus Nerve Stimulation (VNS)
• Gastric Electrical Stimulation (GES)
• Transcranial Magnetic Stimulation (TMS)
• Transcutaneous Electrical Nerve Stimulation (TENS)

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Chronic Pain
• Parkinson's Disease
• Urine Incontinence
• Epilepsy
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Neuromodulation Devices Market Report 2017

1 NEUROMODULATION DEVICES OVERVIEW

1.1 Product Overview and Scope of Neuromodulation Devices
1.2 Classification of Neuromodulation Devices by Product Category
  1.2.1 United States Neuromodulation Devices Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Neuromodulation Devices Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Deep Brain Stimulation (DBS) Systems
  1.2.4 Spinal Cord Stimulator (SCS) Systems
  1.2.5 Diaphragm Pacing System (DPS)
  1.2.6 Respiratory Electrical Stimulation (RES)
  1.2.7 Vagus Nerve Stimulation (VNS)
  1.2.8 Gastric Electrical Stimulation (GES)
  1.2.9 Transcranial Magnetic Stimulation (TMS)
  1.2.10 Transcutaneous Electrical Nerve Stimulation (TENS)
1.3 United States Neuromodulation Devices Market by Application/End Users
  1.3.1 United States Neuromodulation Devices Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Chronic Pain
  1.3.3 Parkinson's Disease
  1.3.4 Urine Incontinence
  1.3.5 Epilepsy
  1.3.6 Others
1.4 United States Neuromodulation Devices Market by Region
  1.4.1 United States Neuromodulation Devices Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Neuromodulation Devices Status and Prospect (2012-2022)
  1.4.3 Southwest Neuromodulation Devices Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Neuromodulation Devices Status and Prospect (2012-2022)
  1.4.5 New England Neuromodulation Devices Status and Prospect (2012-2022)
  1.4.6 The South Neuromodulation Devices Status and Prospect (2012-2022)
  1.4.7 The Midwest Neuromodulation Devices Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Neuromodulation Devices (2012-2022)
  1.5.1 United States Neuromodulation Devices Sales and Growth Rate (2012-2022)
  1.5.2 United States Neuromodulation Devices Revenue and Growth Rate (2012-2022)

2 UNITED STATES NEUROMODULATION DEVICES MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Neuromodulation Devices Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Neuromodulation Devices Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Neuromodulation Devices Average Price by Players/Suppliers (2012-2017)
2.4 United States Neuromodulation Devices Market Competitive Situation and Trends
  2.4.1 United States Neuromodulation Devices Market Concentration Rate
  2.4.2 United States Neuromodulation Devices Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Neuromodulation Devices Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES NEUROMODULATION DEVICES SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Neuromodulation Devices Sales and Market Share by Region (2012-2017)
3.2 United States Neuromodulation Devices Revenue and Market Share by Region (2012-2017)
3.3 United States Neuromodulation Devices Price by Region (2012-2017)

4 UNITED STATES NEUROMODULATION DEVICES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Neuromodulation Devices Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Neuromodulation Devices Revenue and Market Share by Type (2012-2017)
4.3 United States Neuromodulation Devices Price by Type (2012-2017)
4.4 United States Neuromodulation Devices Sales Growth Rate by Type (2012-2017)

5 UNITED STATES NEUROMODULATION DEVICES SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Neuromodulation Devices Sales and Market Share by Application (2012-2017)
5.2 United States Neuromodulation Devices Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES NEUROMODULATION DEVICES PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Medtronic
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Neuromodulation Devices Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Medtronic Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Boston Scientific Corporation
  6.2.2 Neuromodulation Devices Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Boston Scientific Corporation Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 St.Jude Medical
  6.3.2 Neuromodulation Devices Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 St.Jude Medical Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Synapse Biomedical
  6.4.2 Neuromodulation Devices Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Synapse Biomedical Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Nevro
  6.5.2 Neuromodulation Devices Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Nevro Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Neurosigma
  6.6.2 Neuromodulation Devices Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Neurosigma Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Neuropace
  6.7.2 Neuromodulation Devices Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Neuropace Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Neuronetics
  6.8.2 Neuromodulation Devices Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Neuronetics Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Cyberonics
  6.9.2 Neuromodulation Devices Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Cyberonics Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 BioControl Medical
  6.10.2 Neuromodulation Devices Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 BioControl Medical Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 NEUROMODULATION DEVICES MANUFACTURING COST ANALYSIS

7.1 Neuromodulation Devices Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Neuromodulation Devices

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Neuromodulation Devices Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Neuromodulation Devices Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES NEUROMODULATION DEVICES MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Neuromodulation Devices Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Neuromodulation Devices Sales Volume Forecast by Type (2017-2022)
11.3 United States Neuromodulation Devices Sales Volume Forecast by Application (2017-2022)
11.4 United States Neuromodulation Devices Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Neuromodulation Devices
Figure United States Neuromodulation Devices Market Size (K Units) by Type (2012-2022)
Figure United States Neuromodulation Devices Sales Volume Market Share by Type (Product Category) in 2016
Figure Deep Brain Stimulation (DBS) Systems Product Picture
Figure Spinal Cord Stimulator (SCS) Systems Product Picture
Figure Diaphragm Pacing System (DPS) Product Picture
Figure Respiratory Electrical Stimulation (RES) Product Picture
Figure Vagus Nerve Stimulation (VNS) Product Picture
Figure Gastric Electrical Stimulation (GES) Product Picture
Figure Transcranial Magnetic Stimulation (TMS) Product Picture
Figure Transcutaneous Electrical Nerve Stimulation (TENS) Product Picture
Figure United States Neuromodulation Devices Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Neuromodulation Devices by Application in 2016
Figure Chronic Pain Examples
Table Key Downstream Customer in Chronic Pain
Figure Parkinson's Disease Examples
Table Key Downstream Customer in Parkinson's Disease
Figure Urine Incontinence Examples
Table Key Downstream Customer in Urine Incontinence
Figure Epilepsy Examples
Table Key Downstream Customer in Epilepsy
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Neuromodulation Devices Market Size (Million USD) by Region (2012-2022)
Figure The West Neuromodulation Devices Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Neuromodulation Devices Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Neuromodulation Devices Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Neuromodulation Devices Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Neuromodulation Devices Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Neuromodulation Devices Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Neuromodulation Devices Sales (K Units) and Growth Rate (2012-2022)
Figure United States Neuromodulation Devices Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Neuromodulation Devices Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Neuromodulation Devices Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Neuromodulation Devices Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Neuromodulation Devices Sales Share by Players/Suppliers
Figure 2017 United States Neuromodulation Devices Sales Share by Players/Suppliers
Figure United States Neuromodulation Devices Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Neuromodulation Devices Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Neuromodulation Devices Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Neuromodulation Devices Revenue Share by Players/Suppliers
Figure 2017 United States Neuromodulation Devices Revenue Share by Players/Suppliers
Table United States Market Neuromodulation Devices Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Neuromodulation Devices Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Neuromodulation Devices Market Share of Top 3 Players/Suppliers
Figure United States Neuromodulation Devices Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Neuromodulation Devices Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Neuromodulation Devices Product Category
Table United States Neuromodulation Devices Sales (K Units) by Region (2012-2017)
Table United States Neuromodulation Devices Sales Share by Region (2012-2017)
Figure United States Neuromodulation Devices Sales Share by Region (2012-2017)
Figure United States Neuromodulation Devices Sales Market Share by Region in 2016
Table United States Neuromodulation Devices Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Neuromodulation Devices Revenue Share by Region (2012-2017)
Figure United States Neuromodulation Devices Revenue Market Share by Region (2012-2017)
Figure United States Neuromodulation Devices Revenue Market Share by Region in 2016
Table United States Neuromodulation Devices Price (USD/Unit) by Region (2012-2017)
Table United States Neuromodulation Devices Sales (K Units) by Type (2012-2017)
Table United States Neuromodulation Devices Sales Share by Type (2012-2017)
Figure United States Neuromodulation Devices Sales Share by Type (2012-2017)
Figure United States Neuromodulation Devices Sales Market Share by Type in 2016
Table United States Neuromodulation Devices Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Neuromodulation Devices Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Neuromodulation Devices by Type (2012-2017)
Figure Revenue Market Share of Neuromodulation Devices by Type in 2016
Table United States Neuromodulation Devices Price (USD/Unit) by Types (2012-2017)
Figure United States Neuromodulation Devices Sales Growth Rate by Type (2012-2017)
Table United States Neuromodulation Devices Sales (K Units) by Application (2012-2017)
Table United States Neuromodulation Devices Sales Market Share by Application (2012-2017)
Figure United States Neuromodulation Devices Sales Market Share by Application (2012-2017)
Figure United States Neuromodulation Devices Sales Market Share by Application in 2016
Table United States Neuromodulation Devices Sales Growth Rate by Application (2012-2017)
Figure United States Neuromodulation Devices Sales Growth Rate by Application (2012-2017)
Table Medtronic Basic Information List
Table Medtronic Neuromodulation Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Medtronic Neuromodulation Devices Sales Growth Rate (2012-2017)
Figure Medtronic Neuromodulation Devices Sales Market Share in United States (2012-2017)
Figure Medtronic Neuromodulation Devices Revenue Market Share in United States (2012-2017)
Table Boston Scientific Corporation Basic Information List
Table Boston Scientific Corporation Neuromodulation Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boston Scientific Corporation Neuromodulation Devices Sales Growth Rate (2012-2017)
Figure Boston Scientific Corporation Neuromodulation Devices Sales Market Share in United States (2012-2017)
Figure Boston Scientific Corporation Neuromodulation Devices Revenue Market Share in United States (2012-2017)
Table St.Jude Medical Basic Information List
Table St.Jude Medical Neuromodulation Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure St.Jude Medical Neuromodulation Devices Sales Growth Rate (2012-2017)
Figure St.Jude Medical Neuromodulation Devices Sales Market Share in United States (2012-2017)
Figure St.Jude Medical Neuromodulation Devices Revenue Market Share in United States (2012-2017)
Table Synapse Biomedical Basic Information List
Table Synapse Biomedical Neuromodulation Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Synapse Biomedical Neuromodulation Devices Sales Growth Rate (2012-2017)
Figure Synapse Biomedical Neuromodulation Devices Sales Market Share in United States (2012-2017)
Figure Synapse Biomedical Neuromodulation Devices Revenue Market Share in United States (2012-2017)
Table Nevro Basic Information List
Table Nevro Neuromodulation Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Nevro Neuromodulation Devices Sales Growth Rate (2012-2017)
Figure Nevro Neuromodulation Devices Sales Market Share in United States (2012-2017)
Figure Nevro Neuromodulation Devices Revenue Market Share in United States (2012-2017)
Table Neurosigma Basic Information List
Table Neurosigma Neuromodulation Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Neurosigma Neuromodulation Devices Sales Growth Rate (2012-2017)
Figure Neurosigma Neuromodulation Devices Sales Market Share in United States (2012-2017)
Figure Neurosigma Neuromodulation Devices Revenue Market Share in United States (2012-2017)
Table Neuropace Basic Information List
Table Neuropace Neuromodulation Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Neuropace Neuromodulation Devices Sales Growth Rate (2012-2017)
Figure Neuropace Neuromodulation Devices Sales Market Share in United States (2012-2017)
Figure Neuropace Neuromodulation Devices Revenue Market Share in United States (2012-2017)
Table Neuronetics Basic Information List
Table Neuronetics Neuromodulation Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Neuronetics Neuromodulation Devices Sales Growth Rate (2012-2017)
Figure Neuronetics Neuromodulation Devices Sales Market Share in United States (2012-2017)
Figure Neuronetics Neuromodulation Devices Revenue Market Share in United States (2012-2017)
Table Cyberonics Basic Information List
Table Cyberonics Neuromodulation Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cyberonics Neuromodulation Devices Sales Growth Rate (2012-2017)
Figure Cyberonics Neuromodulation Devices Sales Market Share in United States (2012-2017)
Figure Cyberonics Neuromodulation Devices Revenue Market Share in United States (2012-2017)
Table BioControl Medical Basic Information List
Table BioControl Medical Neuromodulation Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure BioControl Medical Neuromodulation Devices Sales Growth Rate (2012-2017)
Figure BioControl Medical Neuromodulation Devices Sales Market Share in United States (2012-2017)
Figure BioControl Medical Neuromodulation Devices Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neuromodulation Devices
Figure Manufacturing Process Analysis of Neuromodulation Devices
Figure Neuromodulation Devices Industrial Chain Analysis
Table Raw Materials Sources of Neuromodulation Devices Major Players/Suppliers in 2016
Table Major Buyers of Neuromodulation Devices
Table Distributors/Traders List
Figure United States Neuromodulation Devices Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Neuromodulation Devices Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Neuromodulation Devices Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Neuromodulation Devices Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Neuromodulation Devices Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Neuromodulation Devices Sales Volume (K Units) Forecast by Type in 2022
Table United States Neuromodulation Devices Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Neuromodulation Devices Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Neuromodulation Devices Sales Volume (K Units) Forecast by Application in 2022
Table United States Neuromodulation Devices Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Neuromodulation Devices Sales Volume Share Forecast by Region (2017-2022)
Figure United States Neuromodulation Devices Sales Volume Share Forecast by Region (2017-2022)
Figure United States Neuromodulation Devices Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources